HDIM
TEVA icon

Hanson & Doremus Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,571
Closed -$34K 540
2022
Q1
$34K Sell
3,571
-1,035
-22% -$9.85K 0.01% 351
2021
Q4
$37K Hold
4,606
0.01% 330
2021
Q3
$45K Sell
4,606
-13,836
-75% -$135K 0.01% 305
2021
Q2
$166K Buy
18,442
+3,595
+24% +$32.4K 0.05% 175
2021
Q1
$171K Sell
14,847
-250
-2% -$2.88K 0.04% 193
2020
Q4
$146K Sell
15,097
-3,345
-18% -$32.3K 0.04% 200
2020
Q3
$166K Sell
18,442
-310
-2% -$2.79K 0.05% 175
2020
Q2
$231K Sell
18,752
-2,722
-13% -$33.5K 0.07% 144
2020
Q1
$193K Sell
21,474
-262
-1% -$2.36K 0.07% 154
2019
Q4
$213K Sell
21,736
-8,582
-28% -$84.1K 0.06% 168
2019
Q3
$209K Sell
30,318
-11,481
-27% -$79.1K 0.07% 167
2019
Q2
$386K Buy
41,799
+395
+1% +$3.65K 0.12% 119
2019
Q1
$649K Sell
41,404
-2,672
-6% -$41.9K 0.21% 95
2018
Q4
$680K Sell
44,076
-4,503
-9% -$69.5K 0.25% 90
2018
Q3
$1.05M Buy
48,579
+277
+0.6% +$5.96K 0.33% 72
2018
Q2
$1.18M Sell
48,302
-146
-0.3% -$3.55K 0.39% 68
2018
Q1
$828K Buy
48,448
+3,358
+7% +$57.4K 0.26% 93
2017
Q4
$854K Sell
45,090
-15,345
-25% -$291K 0.28% 88
2017
Q3
$1.06M Buy
60,435
+907
+2% +$16K 0.37% 74
2017
Q2
$1.98M Buy
59,528
+10,020
+20% +$333K 0.73% 32
2017
Q1
$1.59M Buy
49,508
+10,135
+26% +$325K 0.64% 41
2016
Q4
$1.43M Buy
39,373
+7,545
+24% +$274K 0.62% 45
2016
Q3
$1.46M Buy
31,828
+4,412
+16% +$203K 0.68% 44
2016
Q2
$1.38M Sell
27,416
-565
-2% -$28.4K 0.62% 45
2016
Q1
$1.5M Sell
27,981
-485
-2% -$25.9K 0.68% 39
2015
Q4
$1.87M Sell
28,466
-550
-2% -$36.1K 0.85% 32
2015
Q3
$1.64M Sell
29,016
-1,090
-4% -$61.5K 0.79% 36
2015
Q2
$1.78M Sell
30,106
-995
-3% -$58.8K 0.76% 39
2015
Q1
$1.94M Sell
31,101
-525
-2% -$32.7K 0.82% 38
2014
Q4
$1.82M Sell
31,626
-190
-0.6% -$10.9K 0.78% 37
2014
Q3
$1.71M Hold
31,816
0.77% 39
2014
Q2
$1.67M Sell
31,816
-180
-0.6% -$9.44K 0.77% 40
2014
Q1
$1.69M Buy
31,996
+815
+3% +$43.1K 0.8% 36
2013
Q4
$1.25M Buy
31,181
+4,070
+15% +$163K 0.6% 52
2013
Q3
$1.02M Buy
27,111
+4,575
+20% +$173K 0.52% 61
2013
Q2
$883K Buy
+22,536
New +$883K 0.48% 65